Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection

Transplant Proc. 1993 Jun;25(3 Suppl 2):57-8.

Authors

C A Cosenza¹, D V Cramer, G Eiras-Hreha, E Cajulis, H K Wang, L Makowka

Affiliation

¹ Department of Surgery, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90211.

PMID: 8516945

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Biphenyl Compounds / therapeutic use*
Cyclosporine / therapeutic use*
Drug Evaluation, Preclinical
Drug Therapy, Combination
Graft Rejection / prevention & control*
Heart Transplantation* / immunology
Immunosuppressive Agents / therapeutic use*
Lymphocyte Activation / drug effects
Phytohemagglutinins / pharmacology
Rats
Rats, Inbred Lew
Stimulation, Chemical
Transplantation, Homologous

Substances

Biphenyl Compounds
Immunosuppressive Agents
Phytohemagglutinins
brequinar
Cyclosporine